Kenyan health authorities have warned the public against inserting cetirizine tablets into the vagina after social media posts promoted the ordinary allergy medicine as a way to create “tightness” or enhance sexual pleasure.
The Pharmacy and Poisons Board (PPB) said in a public safety alert issued on November 4, 2026, that cetirizine is approved for oral use in treating allergic conditions, including allergic rhinitis and urticaria. It is not approved for vaginal use, and there is no established scientific evidence that it can tighten vaginal tissue. (citizen.digital)
Dryness is not tightening
The Pharmaceutical Society of Kenya (PSK), which represents pharmacists, said the online claim wrongly equates reduced lubrication with stronger vaginal muscles or altered anatomy. “Although antihistamines may cause dryness as a side effect, reduced lubrication does not strengthen vaginal muscles or alter vaginal anatomy,” the society said. “Dryness is not tightness.” (blueradio.co.ke)
Cetirizine tablets are formulated to be swallowed. The PPB and PSK warned that placing an oral medicine on sensitive vaginal tissue may cause burning, irritation, soreness, pain and discomfort. It may also disrupt the vagina’s natural protective environment and increase the risk of infection. Reduced lubrication can increase friction and raise the risk of tissue injury rather than improve sexual comfort. (blueradio.co.ke)
People who have already tried the practice should stop and seek medical attention if they develop pain, bleeding, burning, itching, unusual discharge or fever. Health authorities have urged anyone with concerns about vaginal dryness, discomfort or sexual health to consult a qualified clinician or pharmacist instead of following unverified online advice. (blueradio.co.ke)
Pharmacists report pressure on supplies
PSK has also reported increased demand, higher prices and shortages of cetirizine at some pharmacy outlets. The reports have not established a nationwide shortage, but the society warned that viral misinformation could make it harder for allergy patients to obtain a medicine they need for its approved purpose. It urged pharmacies to maintain ethical pricing and dispense medicines responsibly. (kbc.co.ke)
Cetirizine remains an oral antihistamine for allergy treatment. Kenyan regulators’ warning concerns its unapproved vaginal use and the risks of allowing a social-media claim to replace evidence-based medical advice.
